Dylan Wint, MD, details the neuropsychiatric symptoms of dementia and their management.

Rebecca Kuenzler, MD, provides the latest insights on the diagnosis and treatment of amyotrophic lateral sclerosis.

Edward Kilbane, MD, addresses diagnosis of bipolar disorders and details the current treatment landscape.

Charles Bernick, MD, MPH, discusses efficacy, patient selection and safety surveillance for anti-amyloid agents.

Demitre Serletis, MD, PhD, details the current and future use of SEEG in the localization of seizure foci and surgical planning as part of a team that has completed more than 1,000 SEEG cases.

The incidence of behavioral health conditions in individuals with multiple sclerosis is four times higher than those with other neurological conditions. In this episode, Grace Tworek, PsyD, discusses the management of behavioral health conditions in MS.

Bill Clifton, MD, discusses the considerations and value of early intervention in adult idiopathic scoliosis.

Junaid Siddiqui, MD, details the four primary atypical parkinsonian disorders - PSP, MSA, DLB and CBD - and shares effective diagnostic techniques and management strategies, distinguishing them from Parkinson's disease.

Dan Ontaneda, MD, PhD, details the 2024 changes to the McDonald Criteria for multiple sclerosis diagnosis and discusses how these changes may impact and evolve the field.

Imad Najm, MD, explores why temporal lobe epilepsy is among the most challenging epilepsy types to treat and how gene therapy aims to overcome the challenges.